Twitter Beğeni Hilesi

Manikandan Ramalingam, Sr VP-R&D, Granules India will be speaking at the #FDDConclave 2024 | 19th & 20th July 2024 | Le Meridien Hyderabad | Presented by CILICANT Register Now: t.ly/19fddT Viveka Roychowdhury Rajesh Bhatkal Lakshmipriya Nair ASHISH RAMPURE

The year 2023-24 was a transformative year for Granules India, that tested our adaptability and resilience in various ways. To learn more about our journey of ‘Embracing change. Shaping Future,' click here: t.ly/-v6vB #AnnualReport #GranulesIndia

We are pleased to support the #SchoolTransformation Project at Zilla Parishad High School, Gagillapur. Our project focused on school building repairs and renovation to create a bright and welcoming learning environment for the 250+ students enrolled. #CSR #Education

We are passionate about supporting education and empowering future generations! This week, we brought smiles to 550 students in three government schools in rural Karnataka by distributing education kits. Each kit includes a school bag, notebooks and essential stationery.

#Q1WithETNOW | Granules India Q1: Cons PAT at Rs 135 cr vs Rs 48 cr, up 181.1% YoY Granules India

Our Q1FY25 results are out! Click here for more details: shorturl.at/dHxbF

Will oncology be a game changer for Granules India in FY26? MD Krishna Chigurupati shares insights on quarterly numbers, growth outlook and more. Watch🔽 youtube.com/watch?v=7TvLSr…

Stocks In News | Granules India: Gets USFDA nod for trazodone hydrochloride tablets Granules India

We are pleased to announce that we have received ANDA approvals for Trazodone Hydrochloride Tablets USP, 50 mg, 100 mg, 150 mg, and 300 mg. Read More: shorturl.at/7ckSl

Wishing everyone a Happy #IndependenceDay ! At Granules India, we are dedicated to advancing healthcare through innovation and sustainability. Together, let’s pave the way for #ViksitBharat. #IndianIndependenceDay #IndiaAt78 #HappyIndependenceDay2024

We celebrated India’s 78th #IndependenceDay with gratitude and pride across Granules' locations in Bonthapally, Jeedimetla, Genome Valley, Gagillapur, Vizag and Granules Life Sciences Pvt Ltd. #IndependenceDayCelebration #IndianIndependenceDay

Team Granules Consumer Health and Granules Pharmaceuticals Inc. participated in the NACDS TSE in Boston. The event provided a valuable platform to strengthen our presence in the U.S. as a trusted pharmaceutical partner and explore potential collaborations with key stakeholders.

#Investor Priyanka Chigurupati, a second-generation entrepreneur, has defied expectations to become a leading figure in India's male-dominated healthcare industry. Read the story: ow.ly/6MCf50T1KjM #WomenInBusiness #HealthcareIndustry #Entrepreneurship #PharmaLeaders

We are pleased to announce that we have received USFDA’s ANDA approval for Glycopyrrolate Oral Solution 1 mg/5 mL. Read more: shorturl.at/FfIk6

Team Granules is heading to #CPHIMilan this October! With four decades of expertise in high-volume products, we offer a diverse range of healthcare solutions across the globe. Write to us at [email protected] for a one-on-one discussion with our team.

We are excited to meet you at #CPHIMilan in October. Join Team Granules at Booth A34 in Hall 22. To schedule a meeting, please write to us at [email protected]. See you there! #GranulesIndia #Pharma #event #CPHI2024 #CPHI

We enjoyed the festive spirit of #GaneshChaturthi by distributing 3,500 clay Ganesha idols, an initiative led by Granules Trust! By choosing eco-friendly idols, we ensure that our celebrations are filled with love, joy, and respect for nature.